PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM
PHARMANOVIA EXCLUSIVELY LICENCES RIGHTS FOR A NOVEL WAY OF TREATING ACUTE EPILEPSY SEIZURE CLUSTERS IN EUROPE, MIDDLE EAST AND NORTH AFRICA PATENTED BUCCAL FILM TECHNOLOGY HAS THE POTENTIAL TO IMPROVE THE EASE OF ADMINISTRATION FOR CAREGIVERS, PATIENTS AND HCPs LONDON, Sept. 28, 2022…
Comments Off on PHARMANOVIA ENTERS EXCLUSIVE LICENSING COLLABORATION FOR DIAZEPAM BUCCAL FILM